Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
-
(2008/06/13)
More Articles about upstream products of 185147-16-4